TopoTarget A/S Confirms Receipt Of Acceptance-To-File Milestone Payment

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Topotarget A/S hereby confirms the receipt of the milestone payment of USD 10 million and 1 million shares from Spectrum Pharmaceuticals, Inc. related to the US Food and Drug Administration’s (FDA) recent acceptance to file BeleodaqTM (belinostat) for peripheral T-cell lymphoma (PTCL).

Help employers find you! Check out all the jobs and post your resume.

Back to news